John Klimowich Buys CLBK Shares

On June 12, 2026, John Klimowich, the Senior Executive Vice President and Chief Risk Officer at CLBK, purchased 33 shares of the company at $20.7 each. This transaction was not part of a pre-arranged trading plan and was valued at $683.1.

Insider Buying and Selling at CLBK

John Klimowich was not the only insider buying CLBK shares recently. On the same day, President & CEO Thomas Kemly acquired 90 shares at the same price. Other insiders, including Noel Holland and Daria Stacy-Walls Torres, also made purchases. Klimowich had previously bought 34 shares on May 29, 2026, at $20.13 each.

Other Institutional Activity in CLBK

Institutional investors have been active in CLBK as well. Dimensional Fund Advisors LP boosted its position by 51,677 shares, bringing its total to just over 2 million shares valued at about $35.7 million. Meanwhile, BlackRock, Inc. trimmed its holdings by 64,640 shares, ending with approximately 2.3 million shares worth $40.4 million. Vanguard Capital Management LLC and Vanguard Portfolio Management LLC both established new positions in CLBK, with holdings of 1,201,220 and 1,091,647 shares respectively.

Analysts Set New Price Targets

Piper Sandler has consistently maintained a hold rating on CLBK. As of November 24, 2025, the firm set a price target of $17.0. Previously, the firm had reiterated similar ratings and targets, reflecting a cautious outlook. Janney Montgomery initiated coverage with a buy rating and an $18.0 target in October 2023.

Bottom Line

John Klimowich's purchase of CLBK shares signals his confidence in the company. Institutional investors have also been adjusting their positions, reflecting varied sentiment. Analysts like Piper Sandler continue to maintain a hold rating, suggesting a steady outlook. Keep in mind that insider transactions and institutional moves are backward-looking and may not reflect current conditions.